The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
scientific article
Author/s
author: Eivind Berge, Peter Sandercock, Richard I Lindley, Gordon Murray, Anna Członkowska, Graeme J. Hankey, Gord Gubitz, Joanna Wardlaw, Adam Kobayashi, Pippa J Tyrrell, Chris Armit, Philip M W Bath, Karl Matz, Phillippe Lyrer
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.